Corbus Pharma (CRBP)
8.11
-0.13 (1.58%)
Upcoming Events
Latest Headlines
H.C. Wainwright Reiterates Buy Rating on Corbus Pharmaceuticals (CRBP)
August 26, 2026 6:42 AM - StreetInsider
Form 4 Corbus Pharmaceuticals For: Aug 16 Filed by: Nicacio Leonardo Viana
August 17, 2026 4:30 PM - SEC Filing
Corbus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 17, 2026 10:00 AM - Globe NewsWire
Form SCHEDULE 13G/A Corbus Pharmaceuticals Filed by: CITADEL ADVISORS LLC
August 14, 2026 4:05 PM - SEC Filing
Corbus Pharmaceuticals (CRBP) PT Lowered to $33 at Mizuho
August 13, 2026 6:36 AM - StreetInsider
Form 4 Corbus Pharmaceuticals For: Aug 11 Filed by: Saxena Nishant C
August 12, 2026 4:30 PM - SEC Filing
Form 4 Corbus Pharmaceuticals For: Aug 07 Filed by: Cohen Yuval
August 10, 2026 4:31 PM - SEC Filing
Form 4 Corbus Pharmaceuticals For: Aug 07 Filed by: Moran Sean F.
August 10, 2026 4:30 PM - SEC Filing
Form 424B5 Corbus Pharmaceuticals
August 7, 2026 4:34 PM - SEC Filing
Form 144 Corbus Pharmaceuticals Filed by: Stifel, Nicolaus & Company, Inc CIAS /FA
August 7, 2026 4:24 PM - SEC Filing
Form 144 Corbus Pharmaceuticals Filed by: Stifel, Nicolaus & Company, Inc CIAS /FA
August 7, 2026 4:05 PM - SEC Filing
Corbus Pharmaceuticals (CRBP) PT Lowered to $48 at Oppenheimer
August 7, 2026 8:04 AM - StreetInsider
Form 10-Q Corbus Pharmaceuticals For: Jun 30
August 6, 2026 4:41 PM - SEC Filing
Form 8-K Corbus Pharmaceuticals For: Aug 06
August 6, 2026 8:15 AM - SEC Filing
Corbus Pharma (CRBP) Misses Q2 EPS by 55c
August 6, 2026 8:13 AM - StreetInsider
Corbus Pharmaceuticals Reports Q2 2026 Financial Results and Provides a Corporate Update
August 6, 2026 8:01 AM - Globe NewsWire
Form 3 Corbus Pharmaceuticals For: Aug 03 Filed by: Nicacio Leonardo Viana
August 4, 2026 4:31 PM - SEC Filing
Corbus Pharmaceuticals Announces Last Patient Last Visit in CANYON-1 Study of CRB-913 for the Treatment of Obesity
August 4, 2026 8:30 AM - Globe NewsWire
FDA clears Corbus Pharma to begin CRB-701 cancer study
July 28, 2026 8:03 AM - StreetInsider
Corbus Pharmaceuticals Announces FDA Clearance to Initiate TEMPO-1 Registrational Study of CRB-701 in Patients with 2L Oropharyngeal Cancer
July 28, 2026 8:01 AM - Globe NewsWire
Form SCHEDULE 13G Corbus Pharmaceuticals Filed by: BlackRock, Inc.
July 27, 2026 4:27 PM - SEC Filing
Form 144 Corbus Pharmaceuticals Filed by: Smethurst Dominic
July 27, 2026 4:07 PM - SEC Filing
Form 8-K Corbus Pharmaceuticals For: Jul 02
July 6, 2026 8:16 AM - SEC Filing
Corbus Pharmaceuticals names new chief medical officer
July 6, 2026 8:01 AM - StreetInsider
Corbus Pharmaceuticals Appoints Leonardo Viana Nicacio, M.D. as Chief Medical Officer
July 6, 2026 8:00 AM - Globe NewsWire
Corbus Pharmaceuticals (CRBP) PT Lowered to $34 at Mizuho
June 23, 2026 9:59 AM - StreetInsider
Form S-8 Corbus Pharmaceuticals
June 17, 2026 4:31 PM - SEC Filing
Corbus Pharmaceuticals (CRBP) PT Lowered to $52 at Oppenheimer
June 17, 2026 6:03 AM - StreetInsider
Corbus Pharmaceuticals (CRBP) PT Lowered to $52 at Oppenheimer
June 17, 2026 6:02 AM - StreetInsider
Full Article List
